During the past decade, Grand Hôpital de Charleroi Oncologie-Hématologie conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Grand Hôpital de Charleroi Oncologie-Hématologie" #1 collaborator was "Breast International Group" with 2 trials as a collaborator, "ADIR, a Servier Group company" with 1 trials as a collaborator, "Austrian Breast & Colorectal Cancer Study Group" with 1 trials as a collaborator, "NSABP Foundation Inc" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Grand Hôpital de Charleroi Oncologie-Hématologie" are "Breast Cancer" (2 trials), "Metastatic Colorectal Cancer" (1 trials), "Non-Small Cell Lung Cancer" (1 trials) and "Ovarian Cancer" (1 trials). Many other conditions were trialed in "Grand Hôpital de Charleroi Oncologie-Hématologie" in a lesser frequency.

Most popular intervention types in "Grand Hôpital de Charleroi Oncologie-Hématologie" are "Drug" (5 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Active Comparator (erlotinib)" (1 trials), "Capecitabine + bevacizumab" (1 trials), "Dacomitinib (PF-00299804)" (1 trials), "NovoTTF-100L(O)" (1 trials) and "Paclitaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Grand Hôpital de Charleroi Oncologie-Hématologie" are 3 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Grand Hôpital de Charleroi Oncologie-Hématologie". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Grand Hôpital de Charleroi Oncologie-Hématologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Grand Hôpital de Charleroi Oncologie-Hématologie, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".